The Santé Cannabis Model of Care
Setting the Global Standard for Medical Cannabis Clinical Practice Leading Patient Service, Clinical Care Standards and Clinical Research Data Collection in Cannabinoid-Based Medicines By Erin…
medical cannabis treatments
Multiple Sclerosis and Cannabinoid-based Medicines
No two cases of Multiple Sclerosis (MS) look the same – the trajectories, outcomes, symptoms and experiences of those living with MS vary from person…
We Answer the Call – National Nursing Week ’21
NURSES AND AUXILIARY NURSES APPRECIATION WEEK 2021 Most of us have experienced the healthcare system, in times of darkness, stress, confusion, and often, in those…
Multiple Sclerosis and Nabiximols: What to Consider When Treating Spasticity
Multiple sclerosis is a progressive, chronic neurodegenerative disease that impacts over 80,000 people in Canada, and more than 2.3 million people globally. In August 2010, nabiximols…
Mindfulness As A Way to Reduce Pain and Stress
By Dr. Michael Dworkind, Medical Director and Co-founder of Santé Cannabis. For more than two months now, Canadians have been living with the stress of…
IBS and Medical Cannabis: The State of Research and Clinical Practice
Irritable Bowel Syndrome, or IBS, is the most common gastro-intestinal diagnosis. It is also one of the most difficult to treat, often leaving patients and…